Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life

Long-acting injectable antipsychotics (LAIs) were developed to make treatment easier, improve adherence, and/or signal the clinician when nonadherence occurs. Second-generation antipsychotic LAIs (SGA-LAIs) combine the advantages of SGA with a long-acting formulation. The purpose of this review is t...

Full description

Saved in:
Bibliographic Details
Published in:Neuropsychiatr Dis Treat
Main Authors: Montemagni, Cristiana, Frieri, Tiziana, Rocca, Paola
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2016
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4844443/
https://ncbi.nlm.nih.gov/pubmed/27143893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S88632
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items